International Journal of Surgical Pathology · 2002 · 57 citations · 56 references
Veterinary MedicineOncologyPathologyMolecular OncologyNeoplasiaOncogenesCancer Cell SignalingGrowth Factor SignalingMalignant NeoplasmsMammary TumorsTumor BiologyBreast Cancer Molecular SubtypesClinicopathological CorrelationDisease-specific SurvivalGrowth FactorsHistologic GradeKaplan-meier Confidence IntervalsKaplan-meier Survival EstimatesMalignant Breast Tumors
Expression of EGF, HB-EGF, TGF-alpha, HRG-alpha, HRG-beta1, and HRG-beta3 in 100 frozen breast carcinoma materials was immunohistochemically studied. Among these tumors, 67% were positive for EGF, 53% for HB-EGF, 57% for TGF-alpha, 60% for HRG-alpha, 53% for HRG-beta1, and 63% for HRG-beta3 in the neoplastic epithelial cells. No significant associations between expression of the growth factors and clinicopathological features like tumor size, histologic grade, node status, ploidy, ER status, and c-erbB-4 expression were observed, with the exceptions that significant relations were present between EGF expression and tumor size (p = 0.01) and between HRG-beta3 expression and node status (p = 0.02). The expressions of these growth factors showed no association with cancer-specific survival by the Kaplan Meier analysis.
56
A Heparin-Binding Growth Factor Secreted by Macrophage-Like Cells That Is Related to EGF
Shigeki Higashiyama, Judith A. Abraham, John C. Fiddes et al. · Science · 1991 · 1.1K citations
Identification of Heregulin, a Specific Activator of p185 <sup>erbB2</sup>
William E. Holmes, Mark X. Sliwkowski, Robert W. Akita et al. · Science · 1992 · 965 citations